Patent US5075229A successfully refreshed from Google Patents.
US5075229A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Dietary and hormonal regulation of expression of exogenous genes in transgenic animals under control of the promoter of the gene for phosphoenolpyruvate carboxykinase
Assignee: EDISON ANIMAL BIOTECHNOLOGY CENTER 116 WILSON HALL/WEST GREEN OHIO UNIVERSITY ATHENS OH 45701
•
Filing: 1988-06-13
•
Granted: 1991-12-24
•
Expires: 2008-06-13
Abstract
Abstract A transgenic animal is constructed in which one or more cells contain a promoter to the gene for cytosolic PEPCK operably linked to a non-PEPCK gene of interest. Expression of this gene is controlled by modifying the protein and carbohydrate components of the animal's diet, or by direct hormonal regulation. The PEPCK promoter is induced by high protein and inhibited by high carbohydrate, or more directly by cAMP and insulin. The linked gene is expressed essentially only after bith and essentially only in particular tissues. The PEPCK promoter has a extremely high promoter strength.
Inventors
- 👤 Richard W. Hanson
- 👤 Mary McGrane
- 👤 Jay Short
- 👤 Maria Hatzoglou
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 16:28
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/85; C12N15/8509; A; A01; A01K; A01K67/00; A01K67/027; A01K67/0275; A01K2217/00; A01K2217/05; A01K2217/20; A01K2227/00; A01K2227/10; A01K2227/105; A01K2267/00; A01K2267/02; A01K2267/03; C12N2830/00; C12N2830/008
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
108 words
A method of introducing a gene into the liver cells of a mammal in utero which comprises providing a retroviral vector bearing an expressible gene which is foreign to an individual recipient fetal mammal and operably linked to a liver-specific promoter, injecting the vector into the peritoneal cavity of said mammal while it is in a fetal stage of development, and permitting development of said mammal from the fetal stage, during which development the vector is transported to the fetal liver, infects endogenous hemopoietic cells of said fetal liver, and integrates into the genome of said cells conferring on said infected cells the ability to express said gene.
Claim 2
Independent Claim
108 words
A method of introducing a gene into the liver cells of a mammal in utero which comprises providing a retroviral vector bearing an expressible gene which is foreign to an individual recipient fetal mammal and operably linked to a liver-specific promoter, injecting the vector into the peritoneal cavity of said mammal while it is in a fetal stage of development, and permitting development of said mammal from the fetal stage, during which development the vector is transported to the fetal liver, infects endogenous hemopoietic cells of said fetal liver, and integrates into the genome of said cells conferring on said infected cells the ability to express said gene.
Claim 3
Dependent Claim
16 words
The method of claim 1 in which the gene is operably linked to a PEPCK promoter.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-12-23 | 1995-06-24 | 1995-12-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-12-23 | 1999-06-24 | 1999-12-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-12-23 | 2003-06-24 | 2003-12-24 | $7700.00 | Window Closed / Lapsed |